Smith & Nephew acquire Rotation Medical for $210M: 4 key points

Mackenzie Garrity -   Print  |

Smith & Nephew completed the acquisition tissue regeneration developer Rotation Medical for $210 million.

Here are four key points:


1. The acquisition costs include $125 million up front and up to an additional $85 million over the next five years, which is contingent on financial performance.


2. Rotation Medical is the developer of an innovative tissue regeneration technology for shoulder rotator cuff repair. Smith & Nephew believes the system will compliment its current shoulder repair technologies portfolio.


3. Rotation Medical's regeneration technology will be sold through Smith & Nephew's sports medicine task force and the integrated Rotation Medical sales team.


4. The rotator cuff repair technology is approved for sale in the U.S., and Smith & Nephew filed for approval in Europe.


More articles on devices and implants:
FDA releases new guidance for 3-D printing medical devices: 5 things to know
Exactech receives $737M offer from TPG Capital to purchase the company: 3 notes
Global spinal fusion devices market to reach nearly $11B by 2025: 6 observations

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers